Insertion of Frontal Ventricular Catheter of VP Shunt in Congenital Hydrocephalus Guided by Trans Fontanelle Ultrasound
Launched by ASSIUT UNIVERSITY · Oct 28, 2024
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to place a special tube called a ventricular shunt in children with a condition called congenital hydrocephalus, which causes fluid to build up in the brain. The researchers want to see if using ultrasound, a safe imaging technique that uses sound waves, can help reduce the chances of the shunt getting blocked after it is put in place. This is important because blockages can lead to serious problems.
To participate in the trial, children must be under 2 years old, have a specific type of soft spot on their head called a patent anterior fontanelle, and have not had a frontal shunt placed before. The study is not yet recruiting participants, but when it begins, families can expect close monitoring and care from medical professionals who specialize in treating this condition. Overall, the trial aims to improve treatment outcomes for young children with congenital hydrocephalus.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who are diagnosed with congenital Hydrocephalus
- • age of patients : \< 2 years with patent Anterior Fontanelle
- • Not operated with frontal shunt before
- Exclusion Criteria:
- • patients who are diagnosed with congenital Hydrocephalus
- • age of patients : \< 2 years with patent Anterior Fontanelle
- • Not operated with frontal shunt before
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported